Licensing Partners

Neos Therapeutics seeks to partner with pharmaceutical and consumer healthcare companies to expand the reach of prescription and OTC products with controlled release, novel oral delivery and dosing options. Working together, the opportunity exists to create and commercialize new products and line extensions in CR liquid and CR Orally Disintegrating Tablet (ODT) dosage forms.

The company’s proprietary technologies can be used to develop controlled release (CR) products in both liquid and solid dosage forms:

• Liquid Technology – Dynamic Time Release Suspension^® (DTRS^®)
  
  
• ODT Technology – Rapidly Disintegrating Ionic Masking™ (RDIM™)
  

Partnering Contact

For licensing inquiries please contact: BD@neostx.com